跳至主要内容
临床试验/NL-OMON56716
NL-OMON56716尚未招募不适用

Bronchial thermoplasty (BT) for severe asthma in the biologic era: a randomized controlled trial (BOOSTER trial) - BOOSTER trial

Academisch Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -adult (>18 years)
  • -severe uncontrolled asthma (defined as ACQ above 1.5) despite optimal medical
  • therapy (GINA treatment step 5; alternative diseases excluded, therapy
  • compliance and adequate inhalation technique confirmed)
  • -1 or more trials of treatment with a biologic or ineligible for biologic
  • -2 or more severe asthma exacerbations in the previous year (defined as the
  • need for a course of OCS or doubling dose of maintenance OCS for at least 3
  • consecutive days)
  • -FEV1 >= 50% predicted after 400µg inhaled salbutamol or equivalent

排除标准

  • -chronic OCS therapy at a dose >20 mg/day prednisone equivalent;
  • -anti-coagulation therapy that cannot be stopped temporarily
  • -comorbidities that are a contra-indication for BT (e.g. bronchiectasis, heart
  • -pregnancy;
  • -body mass index >=35;
  • -current or ex-smokers with >20 pack years;
  • -DLCOc <70%
  • -Subject uses an internal or external pacemaker or cardiac defibrillator

研究者

相似试验